Fallopian TubesOvarian NeoplasmsFallopian Tube NeoplasmsNeoplasms, Glandular and EpithelialOvaryFallopian Tube DiseasesCystadenocarcinoma, SerousFallopian Tube Patency TestsCA-125 AntigenAdenocarcinoma, Clear CellCarcinoma, EndometrioidPeritoneal NeoplasmsCarcinomaAdenocarcinoma, MucinousPregnancy, TubalGenes, BRCA1PaclitaxelNeoplasm StagingHysterosalpingographyTumor Markers, BiologicalCell Line, TumorCarboplatinGene Expression Regulation, NeoplasticCystadenocarcinoma, MucinousSalpingitisDrug Resistance, NeoplasmPrognosisGenes, BRCA2CisplatinImmunohistochemistryCystadenoma, SerousPlatinumAntineoplastic Combined Chemotherapy ProtocolsSterilization, TubalSurvival AnalysisNeoplasms, Cystic, Mucinous, and SerousEpithelial CellsCystadenocarcinomaSalpingectomyAntineoplastic AgentsAscitesPlatinum CompoundsDisease-Free SurvivalSecond-Look SurgeryEpididymal Secretory ProteinsNeoplasm Recurrence, LocalNeoplasm InvasivenessPregnancy, EctopicEpitheliumBRCA2 ProteinPelvic NeoplasmsGynecologic Surgical ProceduresReverse Transcriptase Polymerase Chain ReactionEndometrial NeoplasmsTorsion AbnormalityEarly Detection of CancerSurvival RateBRCA1 ProteinInfertility, FemaleRNA, MessengerCase-Control StudiesTreatment OutcomeNeoplasm ProteinsMice, NudeAdenocarcinoma, PapillaryGerm-Line MutationAntigens, Tumor-Associated, CarbohydrateGenetic Predisposition to DiseaseGene Expression ProfilingRisk FactorsRetrospective StudiesNeoplasm MetastasisAntineoplastic Agents, PhytogenicHysterectomyCell ProliferationProspective StudiesPolycystic Ovary SyndromeDisease ProgressionOvariectomyFolate Receptor 1MutationBreast NeoplasmsPollen TubeAltretamineFollow-Up StudiesGenitalia, FemaleTumor Cells, CulturedTumor Suppressor Protein p53Genital Neoplasms, FemaleTalcXenograft Model Antitumor AssaysKaplan-Meier EstimateBlotting, WesternRiskPregnancyMultivariate AnalysisCystadenocarcinoma, PapillaryOdds RatioTopotecanCombined Modality Therapy